Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSavant Capital, LLC
Latest Disclosed Ownership3,856 shares
Latest Disclosed Value $ 1,721,681
Savant Capital, LLC reports 13.18% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 4, 2026 - Savant Capital, LLC filed a 13F-HR form disclosing ownership of 3,856 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $1,721,858 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 3,407 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 13.18% during the quarter. The current value of the position is $1,651,679 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,856 449 13.18 1,722 11.46 0.0083
2026-02-10 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,407 481 16.44 1,544 34.73 0.0088
2026-03-04 2025-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,926 411 16.34 1,146 2.41 0.0070
2025-11-05 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,617 480 1,417 0.0075
2026-03-04 2025-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,515 327 14.95 1,120 5.57 0.0080
2025-08-06 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,137 -2,868 1,397 0.0087
2026-03-04 2025-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,188 -4,462 -67.10 1,061 -60.42 0.0090
2025-05-08 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,005 -645 2,912 0.0211
2025-01-29 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,650 -383 -5.45 2,678 -18.13 0.0211
2024-11-04 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,033 472 7.19 3,271 6.37 0.0271
2024-08-05 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,561 3,127 91.06 3,075 114.29 0.0308
2024-05-06 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,434 763 28.57 1,436 32.14 0.0165
2024-02-05 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,671 624 30.48 1,087 52.74 0.0140
2023-11-07 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,047 62 3.12 712 1.86 0.0106
2023-08-04 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,985 820 70.39 699 90.19 0.0109
2023-05-03 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,165 244 26.49 367 38.49 0.0068
2023-02-13 2022-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 921 142 18.23 266 17.26 0.0065
2023-02-07 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 921 142 266 0.0065
2022-10-31 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 779 50 6.86 226 10.24 0.0070
2022-07-22 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 729 729 205 0.0062
2016-05-11 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -2,074 -100.00 0 -100.00
2016-02-02 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,074 2,074 261 0.0814
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.